Mizuho Securities Co. Ltd. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 66.4% during the second quarter, Holdings Channel reports. The firm owned 683 shares of the medical equipment provider's stock after selling 1,351 shares during the period. Mizuho Securities Co. Ltd.'s holdings in Intuitive Surgical were worth $245,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Mitchell Mcleod Pugh & Williams Inc. grew its position in shares of Intuitive Surgical by 7.9% during the first quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 679 shares of the medical equipment provider's stock worth $205,000 after acquiring an additional 50 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of Intuitive Surgical by 0.9% during the first quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider's stock worth $133,012,000 after acquiring an additional 3,982 shares during the last quarter. MCIA Inc grew its position in shares of Intuitive Surgical by 5.6% during the first quarter. MCIA Inc now owns 3,596 shares of the medical equipment provider's stock worth $1,003,000 after acquiring an additional 190 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its position in shares of Intuitive Surgical by 2.6% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 37,616 shares of the medical equipment provider's stock worth $7,550,000 after acquiring an additional 952 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. grew its position in shares of Intuitive Surgical by 0.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 88,814 shares of the medical equipment provider's stock worth $26,793,000 after acquiring an additional 578 shares during the last quarter. Institutional investors and hedge funds own 82.44% of the company's stock.
Get Intuitive Surgical alerts:Insider Transactions at Intuitive Surgical
In other news, CEO Gary S. Guthart sold 79,412 shares of the business's stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $216.30, for a total transaction of $17,176,815.60. Following the completion of the sale, the chief executive officer now owns 54,607 shares in the company, valued at approximately $11,811,494.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Intuitive Surgical news, CEO Gary S. Guthart sold 79,412 shares of the company's stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $216.30, for a total value of $17,176,815.60. Following the completion of the transaction, the chief executive officer now owns 54,607 shares in the company, valued at approximately $11,811,494.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 9,000 shares of the company's stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the transaction, the executive vice president now owns 217 shares of the company's stock, valued at approximately $48,825. The disclosure for this sale can be found here. In the last quarter, insiders sold 101,162 shares of company stock worth $22,062,916. 0.90% of the stock is currently owned by company insiders.
Analyst Ratings Changes
ISRG has been the topic of a number of research reports. Evercore ISI lowered their target price on shares of Intuitive Surgical from $210.00 to $175.00 in a research report on Friday, July 22nd. Piper Sandler lifted their price objective on shares of Intuitive Surgical from $255.00 to $260.00 and gave the company an "overweight" rating in a research report on Thursday, August 18th. Wells Fargo & Company lowered their price objective on shares of Intuitive Surgical to $265.00 in a research report on Friday, July 22nd. The Goldman Sachs Group lowered their price objective on shares of Intuitive Surgical from $319.00 to $273.00 and set a "buy" rating on the stock in a research report on Friday, July 29th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of Intuitive Surgical from $225.00 to $205.00 in a research report on Friday, July 22nd. Six analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $268.00.Intuitive Surgical Trading Up 2.1 %
Shares of NASDAQ ISRG traded up $3.90 on Friday, reaching $192.96. 19,332 shares of the company traded hands, compared to its average volume of 1,715,921. Intuitive Surgical, Inc. has a fifty-two week low of $184.94 and a fifty-two week high of $369.69. The company has a 50 day moving average of $216.72 and a 200 day moving average of $230.84. The stock has a market capitalization of $68.91 billion, a PE ratio of 48.11, a P/E/G ratio of 5.36 and a beta of 1.31.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its quarterly earnings data on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). Intuitive Surgical had a net margin of 24.05% and a return on equity of 12.04%. The company had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same period in the prior year, the company earned $1.42 EPS. As a group, research analysts expect that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current year.
Intuitive Surgical Company Profile
(Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- Declining Profits Challenge the CarMax Value Proposition
- How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?
- Let Paychex Stock Work Hard For You
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.